Showing results (1-10 of 481) with videos related to
Sort By:
Pageof 49
Cardiovascular Drugs and Therapy|June 24, 2017
Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading RoleDimitrios Alexopoulos, Panagiotis Vlachakis, John LekakisJournal of Cardiovascular Pharmacology and Therapeutics|December 13, 2017
Cangrelor in Percutaneous Coronary Intervention: Current Status and PerspectivesDimitrios Alexopoulos, Christos Pappas, Danai Sfantou, et al.Platelets|October 13, 2017
Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?Dimitrios Alexopoulos, Konstantinos Katogiannis, Danai Sfantou, et al.Journal of the American College of Cardiology|September 10, 2016
Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients: Facing a New Trilemma?Dimitrios Alexopoulos, Ioanna Xanthopoulou, Athanasios Moulias, et al.Circulation. Cardiovascular Interventions|September 3, 2016
P2Y12 Receptor Antagonists and Morphine: A Dangerous Liaison?Georgios Giannopoulos, Spyridon Deftereos, Fotios Kolokathis, et al.Journal of Hypertension|January 11, 2007
Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up studyIgnatios Ikonomidis, Andreas Mazarakis, Costas Papadopoulos, et al.International Journal of Cardiology|February 8, 2011
Acute myocardial infarction late following stent implantation: Incidence, mechanisms and clinical presentationDimitrios AlexopoulosCardiology|January 25, 2014
p2y12 receptor inhibitors in acute coronary syndromes: from the research laboratory to the clinic and vice versaDimitrios AlexopoulosExpert Review of Hematology|September 21, 2012
Prediction of clopidogrel efficacy and safety: phenotyping and/or genotyping?Dimitrios AlexopoulosPageof 49